Business Description
RBC Bioscience Corp
ISIN : TW0006848005
Total Employee Number:
45Description
RBC Bioscience Corp is a bio-sciences company. Its products include the manufacture and sale of molecular biological medical diagnosis and research reagents, gene extraction automatic testing instruments, and gene extraction reagent tissues.
Financial Strength
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.09 | |||||
Equity-to-Asset | 0.37 | |||||
Debt-to-Equity | 1.55 | |||||
Debt-to-EBITDA | 7.4 | |||||
Interest Coverage | 3.62 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 0.99 | |||||
Beneish M-Score | -1.72 | |||||
WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 7.9 | |||||
3-Year EBITDA Growth Rate | 20.1 | |||||
3-Year EPS without NRI Growth Rate | 85.4 | |||||
3-Year Book Growth Rate | 2.6 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 42.07 | |||||
9-Day RSI | 44.75 | |||||
14-Day RSI | 47.69 | |||||
3-1 Month Momentum % | 9.04 | |||||
6-1 Month Momentum % | 23.87 | |||||
12-1 Month Momentum % | 19.95 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.25 | |||||
Quick Ratio | 0.76 | |||||
Cash Ratio | 0.4 | |||||
Days Inventory | 154.98 | |||||
Days Sales Outstanding | 37.72 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 6.14 | |||||
Dividend Payout Ratio | 0.18 | |||||
3-Year Dividend Growth Rate | -30.9 | |||||
Forward Dividend Yield % | 6.14 | |||||
5-Year Yield-on-Cost % | 5.91 | |||||
Shareholder Yield % | 21.56 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 46.18 | |||||
Operating Margin % | 15.98 | |||||
Net Margin % | 10.72 | |||||
EBITDA Margin % | 25.55 | |||||
FCF Margin % | 12.48 | |||||
OCF Margin % | 18.44 | |||||
ROE % | 9.07 | |||||
ROA % | 3.14 | |||||
ROIC % | 4.02 | |||||
3-Year ROIIC % | -38.54 | |||||
ROC (Joel Greenblatt) % | 7.12 | |||||
ROCE % | 6.17 | |||||
Years of Profitability over Past 10-Year | 8 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 12.5 | |||||
PE Ratio without NRI | 12.47 | |||||
PS Ratio | 1.34 | |||||
PB Ratio | 1.09 | |||||
Price-to-Tangible-Book | 1.16 | |||||
Price-to-Free-Cash-Flow | 10.77 | |||||
Price-to-Operating-Cash-Flow | 7.29 | |||||
EV-to-EBIT | 16.95 | |||||
EV-to-EBITDA | 11.92 | |||||
EV-to-Revenue | 3.05 | |||||
EV-to-FCF | 23.92 | |||||
Price-to-GF-Value | 1.03 | |||||
Price-to-Graham-Number | 0.8 | |||||
Earnings Yield (Greenblatt) % | 5.9 | |||||
FCF Yield % | 9.37 | |||||
Forward Rate of Return (Yacktman) % | -37.83 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
RBC Bioscience Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 219.707 | ||
| EPS (TTM) (NT$) | 1.64 | ||
| Beta | 0.3131 | ||
| 3-Year Sharpe Ratio | 0.19 | ||
| 3-Year Sortino Ratio | 0.36 | ||
| Volatility % | 33.41 | ||
| 14-Day RSI | 47.69 | ||
| 14-Day ATR (NT$) | 1.152741 | ||
| 20-Day SMA (NT$) | 21.1975 | ||
| 12-1 Month Momentum % | 19.95 | ||
| 52-Week Range (NT$) | 14.3 - 25.05 | ||
| Shares Outstanding (Mil) | 14.27 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
RBC Bioscience Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
RBC Bioscience Corp Stock Events
| Event | Date | Price (NT$) | ||
|---|---|---|---|---|
| TWD 1.200000 Cash Dividend | 2026-07-09 | 22.80 (-5.00%) | ||
| TWD 0.300000 Cash Dividend | 2025-10-02 | 18.30 (+0.27%) | ||
| 1.1:1 Stock Split | 2025-08-11 | 17.36 (+0.26%) | ||
| TWD 0.509091 Cash Dividend | 2024-09-19 | 18.55 (+3.03%) | ||
| TWD 0.400000 Cash Dividend | 2024-08-05 | 16.82 (-0.80%) | ||
| 1.1:1 Stock Split | 2022-07-21 | 27.60 (-0.15%) |
Show
Entries
RBC Bioscience Corp Frequently Asked Questions
What is RBC Bioscience Corp(ROCO:6848)'s stock price today?
The current price of ROCO:6848 is NT$20.50. The 52 week high of ROCO:6848 is NT$25.05 and 52 week low is NT$14.30.
When is next earnings date of RBC Bioscience Corp(ROCO:6848)?
The next earnings date of RBC Bioscience Corp(ROCO:6848) is .
Does RBC Bioscience Corp(ROCO:6848) pay dividends? If so, how much?
The Dividend Yield %  of RBC Bioscience Corp(ROCO:6848) is 6.14% (As of Today), Highest Dividend Payout Ratio of RBC Bioscience Corp(ROCO:6848) was 3.52. The lowest was 0.18. And the median was 1.42. The  Forward Dividend Yield % of RBC Bioscience Corp(ROCO:6848) is 6.14%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on RBC Bioscience Corp
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers